AstraZeneca advances its ambition to redefine hematology care with new data from its diverse pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, ...
Resistant hypertension remains a tough adversary in the fight against the global rise of cardiovascular disease, but updated guidance, new tools and new drugs on the horizon provide hope.Hypertension ...
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback